Completed PHASE1/PHASE2 INTERVENTIONAL NCT00494468
Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in Children
Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Zolpidem Doses in Children Ages 2 to 18 Years of Age
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions
Insomnia Sleep Disorder
Interventions
Zolpidem
Updated 1 time since 2024 Last updated: Jun 28, 2007 Started: Oct 31, 2002 Completion: Mar 31, 2004
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00494468, this PHASE1/PHASE2 trial focuses on Insomnia and Sleep Disorder and remains completed. Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), it has been updated 1 time since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE1/PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Sanofi-Synthelabo
Data source: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
For direct contact, visit the study record on ClinicalTrials.gov .